These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 37182789)

  • 1. Direct and systemic actions of growth hormone receptor (GHR)-signaling on hepatic glycolysis, de novo lipogenesis and insulin sensitivity, associated with steatosis.
    Vázquez-Borrego MC; Del Río-Moreno M; Pyatkov M; Sarmento-Cabral A; Mahmood M; Pelke N; Wnek M; Cordoba-Chacon J; Waxman DJ; Puchowicz MA; McGuinness OP; Kineman RD
    Metabolism; 2023 Jul; 144():155589. PubMed ID: 37182789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GH directly inhibits steatosis and liver injury in a sex-dependent and IGF1-independent manner.
    Sarmento-Cabral A; Del Rio-Moreno M; Vazquez-Borrego MC; Mahmood M; Gutierrez-Casado E; Pelke N; Guzman G; Subbaiah PV; Cordoba-Chacon J; Yakar S; Kineman RD
    J Endocrinol; 2021 Jan; 248(1):31-44. PubMed ID: 33112796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice.
    Cordoba-Chacon J; Majumdar N; List EO; Diaz-Ruiz A; Frank SJ; Manzano A; Bartrons R; Puchowicz M; Kopchick JJ; Kineman RD
    Diabetes; 2015 Sep; 64(9):3093-103. PubMed ID: 26015548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult-Onset Hepatocyte GH Resistance Promotes NASH in Male Mice, Without Severe Systemic Metabolic Dysfunction.
    Cordoba-Chacon J; Sarmento-Cabral A; Del Rio-Moreno M; Diaz-Ruiz A; Subbaiah PV; Kineman RD
    Endocrinology; 2018 Nov; 159(11):3761-3774. PubMed ID: 30295789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth Hormone Control of Hepatic Lipid Metabolism.
    Liu Z; Cordoba-Chacon J; Kineman RD; Cronstein BN; Muzumdar R; Gong Z; Werner H; Yakar S
    Diabetes; 2016 Dec; 65(12):3598-3609. PubMed ID: 27679560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic PPARγ Is Not Essential for the Rapid Development of Steatosis After Loss of Hepatic GH Signaling, in Adult Male Mice.
    Kineman RD; Majumdar N; Subbaiah PV; Cordoba-Chacon J
    Endocrinology; 2016 May; 157(5):1728-35. PubMed ID: 26950202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
    Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
    Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards Understanding the Direct and Indirect Actions of Growth Hormone in Controlling Hepatocyte Carbohydrate and Lipid Metabolism.
    Vázquez-Borrego MC; Del Rio-Moreno M; Kineman RD
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism.
    Fan Y; Menon RK; Cohen P; Hwang D; Clemens T; DiGirolamo DJ; Kopchick JJ; Le Roith D; Trucco M; Sperling MA
    J Biol Chem; 2009 Jul; 284(30):19937-44. PubMed ID: 19460757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects of reduced growth hormone action in fatty liver disease.
    Rufinatscha K; Ress C; Folie S; Haas S; Salzmann K; Moser P; Dobner J; Weiss G; Iruzubieta P; Arias-Loste MT; Crespo J; Tilg H; Kaser S
    Hepatol Int; 2018 Sep; 12(5):474-481. PubMed ID: 30206761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
    Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of leptin by metabolic state and its regulatory interactions with pituitary growth hormone and hepatic growth hormone receptors and insulin like growth factors in the tilapia (Oreochromis mossambicus).
    Douros JD; Baltzegar DA; Mankiewicz J; Taylor J; Yamaguchi Y; Lerner DT; Seale AP; Grau EG; Breves JP; Borski RJ
    Gen Comp Endocrinol; 2017 Jan; 240():227-237. PubMed ID: 27449341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone ameliorates high glucose-induced steatosis on in vitro cultured human HepG2 hepatocytes by inhibiting de novo lipogenesis via ChREBP and FAS suppression.
    Villanueva-Ortega E; Méndez-García LA; Garibay-Nieto GN; Laresgoiti-Servitje E; Medina-Bravo P; Olivos-García A; Muñoz-Ortega MH; Ventura-Juárez J; Escobedo G
    Growth Horm IGF Res; 2020; 53-54():101332. PubMed ID: 32698101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional changes of the liver in the absence of growth hormone (GH) action - Proteomic and metabolomic insights from a GH receptor deficient pig model.
    Riedel EO; Hinrichs A; Kemter E; Dahlhoff M; Backman M; Rathkolb B; Prehn C; Adamski J; Renner S; Blutke A; de Angelis MH; Bidlingmaier M; Schopohl J; Arnold GJ; Fröhlich T; Wolf E
    Mol Metab; 2020 Jun; 36():100978. PubMed ID: 32277923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food deprivation reduces sensitivity of liver Igf1 synthesis pathways to growth hormone in juvenile gopher rockfish (Sebastes carnatus).
    Bersin TV; Cordova KL; Journey ML; Beckman BR; Lema SC
    Gen Comp Endocrinol; 2024 Jan; 346():114404. PubMed ID: 37940008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.
    Smith GI; Shankaran M; Yoshino M; Schweitzer GG; Chondronikola M; Beals JW; Okunade AL; Patterson BW; Nyangau E; Field T; Sirlin CB; Talukdar S; Hellerstein MK; Klein S
    J Clin Invest; 2020 Mar; 130(3):1453-1460. PubMed ID: 31805015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of hepatic carbohydrate response element binding protein (ChREBP) impairs glucose homeostasis and hepatic insulin sensitivity in mice.
    Jois T; Chen W; Howard V; Harvey R; Youngs K; Thalmann C; Saha P; Chan L; Cowley MA; Sleeman MW
    Mol Metab; 2017 Nov; 6(11):1381-1394. PubMed ID: 29107286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha blockade restores growth hormone signaling in murine colitis.
    DiFedele LM; He J; Bonkowski EL; Han X; Held MA; Bohan A; Menon RK; Denson LA
    Gastroenterology; 2005 May; 128(5):1278-91. PubMed ID: 15887111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis.
    Heida A; Gruben N; Catrysse L; Koehorst M; Koster M; Kloosterhuis NJ; Gerding A; Havinga R; Bloks VW; Bongiovanni L; Wolters JC; van Dijk T; van Loo G; de Bruin A; Kuipers F; Koonen DPY; van de Sluis B
    Mol Metab; 2021 Dec; 54():101349. PubMed ID: 34626855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifications of the GH Axis Reveal Unique Sexually Dimorphic Liver Signatures for
    Brie B; Sarmento-Cabral A; Pascual F; Cordoba-Chacon J; Kineman RD; Becu-Villalobos D
    J Endocr Soc; 2024 Jan; 8(3):bvae015. PubMed ID: 38370444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.